Header cover image

Danish (OMX) Life Sciences Industry Analysis

UpdatedMay 08, 2025
DataAggregated Company Financials
Companies2
  • 7D-1.0%
  • 3M-28.9%
  • 1Y29.1%
  • YTD-24.8%

Over the last 7 days, the Life Sciences industry has dropped 1.2%, driven by ChemoMetec declining 0.7%. In contrast, Gubra has gained 5.0%. In the past year, the industry has gained 41%. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the Danish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 08 May 2025DKK 14.1bDKK 725.3mDKK 132.6m46.6x106.7x19.5x
Sat, 05 Apr 2025DKK 13.5bDKK 725.3mDKK 132.6m43.7x101.7x18.6x
Mon, 03 Mar 2025DKK 19.3bDKK 725.3mDKK 132.6m59.8x145.6x26.6x
Wed, 29 Jan 2025DKK 18.8bDKK 631.7mDKK 89.8m63.2x209.7x29.8x
Fri, 27 Dec 2024DKK 18.5bDKK 631.7mDKK 89.8m62.3x206.1x29.3x
Sun, 24 Nov 2024DKK 18.7bDKK 631.7mDKK 89.8m60.3x208.6x29.6x
Tue, 22 Oct 2024DKK 14.2bDKK 631.7mDKK 89.8m53.5x158.2x22.5x
Thu, 19 Sep 2024DKK 15.8bDKK 631.7mDKK 89.8m54.8x175.9x25x
Sat, 17 Aug 2024DKK 16.8bDKK 606.5mDKK 99.3m46.6x168.9x27.6x
Mon, 15 Jul 2024DKK 16.4bDKK 606.5mDKK 99.3m46.4x165x27x
Wed, 12 Jun 2024DKK 11.2bDKK 606.5mDKK 99.3m40x112.6x18.4x
Fri, 10 May 2024DKK 10.9bDKK 606.5mDKK 99.3m37.9x110.3x18.1x
Sun, 07 Apr 2024DKK 11.3bDKK 606.5mDKK 99.3m45.6x113.9x18.6x
Tue, 05 Mar 2024DKK 12.5bDKK 606.5mDKK 99.3m63.4x126.3x20.7x
Thu, 01 Feb 2024DKK 8.5bDKK 647.9mDKK 171.7m36.6x49.7x13.2x
Sat, 30 Dec 2023DKK 8.8bDKK 647.9mDKK 171.7m37.8x51.2x13.6x
Mon, 27 Nov 2023DKK 8.2bDKK 647.9mDKK 171.7m35.1x47.5x12.6x
Wed, 25 Oct 2023DKK 6.3bDKK 647.9mDKK 171.7m26.9x36.8x9.7x
Fri, 22 Sep 2023DKK 7.8bDKK 647.9mDKK 171.7m33.6x45.6x12.1x
Sun, 20 Aug 2023DKK 8.9bDKK 660.6mDKK 184.0m213.1x48.2x13.4x
Tue, 18 Jul 2023DKK 9.2bDKK 660.6mDKK 184.0m197x50.2x14x
Thu, 15 Jun 2023DKK 10.5bDKK 660.6mDKK 184.0m205.3x57.2x15.9x
Sat, 13 May 2023DKK 8.8bDKK 660.6mDKK 184.0m204.7x47.6x13.2x
Mon, 10 Apr 2023DKK 6.5bDKK 461.2mDKK 179.7m36.3x36.3x14.1x
Wed, 08 Mar 2023DKK 7.4bDKK 461.2mDKK 179.7m41.3x41.3x16.1x
Fri, 03 Feb 2023DKK 11.4bDKK 428.4mDKK 159.5m71.2x71.2x26.5x
Sun, 01 Jan 2023DKK 12.4bDKK 428.4mDKK 159.5m75.4x77.7x28.9x
Tue, 29 Nov 2022DKK 14.6bDKK 428.4mDKK 159.5m91.7x91.7x34.1x
Thu, 27 Oct 2022DKK 12.5bDKK 428.4mDKK 159.5m78.1x78.1x29.1x
Sat, 24 Sep 2022DKK 10.8bDKK 428.4mDKK 159.5m67.7x67.7x25.2x
Mon, 22 Aug 2022DKK 14.7bDKK 358.0mDKK 131.3m112x112x41.1x
Wed, 20 Jul 2022DKK 12.8bDKK 358.0mDKK 131.3m97.2x97.2x35.6x
Fri, 17 Jun 2022DKK 12.2bDKK 358.0mDKK 131.3m92.7x92.7x34x
Sun, 15 May 2022DKK 11.7bDKK 358.0mDKK 131.3m89.2x89.2x32.7x
Price to Earnings Ratio

89.2x


Total Market Cap: DKK 11.7bTotal Earnings: DKK 131.3mTotal Revenue: DKK 358.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Life Sciences Industry Price to Earnings3Y Average 100.3x202320242025
Current Industry PE
    There are only 2 companies in the Danish Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 27% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market1.60%
Healthcare0.94%
Life Sciences-1.01%
Clinical Research and Equipment-1.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GUBRA GubraDKK 384.403.1%
+DKK 185.9m
13.7%PS23.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.